A recent study by Lundgren et al. explored the predictive value of gene expression (GEX) for the efficacy of tamoxifen in 236 premenopausal breast cancer patients with early-stage ER+/HER2− tumors [56]. Here, ESR1 is linked to breast carcinoma.